المؤلفون: G Palmieri, F Consoli, M Valente, Corrado Caracò, Paolo Antonio Ascierto, Michele Maio, M Guida, G Rinaldi, Angelo Paolo Dei Tos, R Berardi, Giovanni Grignani, Paola Queirolo, Francesca Spada, Nicola Fazio, A Córdova, L Repetto, B Vincenzi, D Massi, G Fabbrocini, A Berruti, L Tagliaferri, P Rubegni, P Poletti, M Barberis, F Picciotto, Paolo Bossi, M Gatti, Vanna Chiarion Sileni, Pietro Quaglino, GC Antonini Cappellini, L Antonuzzo, G Badalamenti, F Bassetto, A Bongiovanni, P Bonomo, L Borgognoni, V Borzillo, F Bruder, D Campana, R Depenni, AM Di Giacomo, MC Fargnoli, V Ferraresi, F Ferrau, MT Fierro, F Gelsomino, D Giuffrida, P Graziano, C Gregorelli, R Mazzarotto, L Milesi, AM Minisini, F Morgese, P Muto, R Patuzzo, G Pellacani, J Pigozzo, N Pimpinelli, G Rubino, F Spagnolo, E Tanda, MC Tronconi, M Tucci, I Zalaudek

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/10/6/e004742.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/803650a72e7f4b7aa71f13ef3550f03b

المؤلفون: Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: annamaria.digiacomo@unisi.it., Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Del Vecchio M; Unit of Melanoma, Medical Oncology, Department of Medical Oncology and Hematology, Istituto Nazionale dei Tumori, Milan, Italy., Ferrucci PF; Department of Oncology Gruppo Multimedica, Milan, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Quaglino P; Dermatology Clinic, Department of Medical Science, University of Turin, Italy., Guidoboni M; University of Ferrara, Italy., Marchetti P; IRCCS IDI-Istituto Dermopatico dell'Immacolata, 00167, Rome, Italy., Simonetti E; University of Siena, Siena, Italy., Santangelo F; University of Siena, Siena, Italy., Amato G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Covre A; University of Siena, Siena, Italy., Camerini R; NIBIT Foundation Onlus, Italy., Valente M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Mandalà M; University of Perugia, Santa Maria della Misericordia, University Hospital of Perugia, Italy., Giannarelli D; Statistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Calabrò L; University of Ferrara, Italy., Maio M; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113981. Date of Electronic Publication: 2024 Mar 09.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Splendiani E; Department of Experimental Medicine, Sapienza University, Rome, Italy., Besharat ZM; Department of Experimental Medicine, Sapienza University, Rome, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy; Medical Oncology, Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy., Ferretti E; Department of Experimental Medicine, Sapienza University, Rome, Italy. Electronic address: elisabetta.ferretti@uniroma1.it.

المصدر: Pharmacology & therapeutics [Pharmacol Ther] 2024 Apr; Vol. 256, pp. 108613. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther

المؤلفون: Roccuzzo G; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy., Gherardi E; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy., Maio M; University of Siena and Center for Immuno-Oncology, University Hospital Le Scotte, Siena, Italy., Malagoli P; Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese, Milan, Italy., Marzano AV; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Parodi A; Section of Dermatology, Department of Health Sciences (DISSAL), IRCCS San Martino University Hospital, Genoa, Italy., Pimpinelli N; Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy.; Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate (DISC), Università degli Studi di Genova, Genova, Italy., Di Giacomo AM; University of Siena and Center for Immuno-Oncology, University Hospital Le Scotte, Siena, Italy., Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.

المصدر: Expert opinion on biological therapy [Expert Opin Biol Ther] 2024 Mar; Vol. 24 (3), pp. 125-131. Date of Electronic Publication: 2024 Mar 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Skin Neoplasms*/drug therapy , Biological Products*/therapeutic use , Psoriasis*/drug therapy, Humans ; Immunotherapy

المؤلفون: Lofiego MF; University of Siena, Siena, Italy., Piazzini F; University of Siena, Siena, Italy., Caruso FP; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy., Marzani F; University of Siena, Siena, Italy., Solmonese L; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Bello E; University of Siena, Siena, Italy., Celesti F; University of Siena, Siena, Italy., Costa MC; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', Naples, Italy., Noviello T; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA., Mortarini R; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Anichini A; Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ceccarelli M; BIOGEM Institute of Molecular Biology and Genetics, Ariano Irpino, Italy.; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.; Department of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA., Coral S; University of Siena, Siena, Italy., Di Giacomo AM; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Maio M; University of Siena, Siena, Italy.; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Covre A; University of Siena, Siena, Italy. alessia.covre2@unisi.it.

مؤلفون مشاركون: EPigenetic Immune-oncology Consortium Airc (EPICA) investigators

المصدر: Journal of translational medicine [J Transl Med] 2024 Mar 01; Vol. 22 (1), pp. 223. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/genetics , Glioblastoma*/therapy , Glioblastoma*/metabolism, Azacitidine/*analogs & derivatives, Humans ; Azacitidine/therapeutic use ; Epigenesis, Genetic ; Immunotherapy

المؤلفون: Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Schenker M; Centrul de Oncologie Sf. Nectarie, Oncologie Medicala, Craiova, Romania., Medioni J; Centre of Early Clinical Trials in Cancer, Hôpital Européen Georges-Pompidou, Université Paris Cité, Paris, France., Mandziuk S; Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, Lublin, Poland., Majem M; Medical Oncology Department, Hospital de Sant Pau, Barcelona, Spain., Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Université, CRCM, Marseille, France., Cornfeld M; Incyte Corporation, Wilmington, USA., Ranganathan S; Incyte Corporation, Wilmington, USA., Lou S; Incyte Corporation, Wilmington, USA., Csoszi T; Hetényi Géza Kórház Onkológiai Központ, Szolnok, Hungary. Electronic address: dr.cstibor@freemail.hu.

المصدر: ESMO open [ESMO Open] 2024 Mar; Vol. 9 (3), pp. 102387. Date of Electronic Publication: 2024 Feb 23.

نوع المنشور: Clinical Trial, Phase II; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Renal Cell*/drug therapy , Melanoma*/drug therapy , Carcinoma, Transitional Cell* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Urinary Bladder Neoplasms*, Humans ; B7-H1 Antigen ; Immune Checkpoint Inhibitors/therapeutic use ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use

المؤلفون: Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy. Electronic address: mario.mandala@unipg.it., Lorigan P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Sergi MC; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy., Benannoune N; Gustave Roussy Cancer Campus, Villejuif, France., Serra P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Giannarelli D; Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Arance AM; Hospital Clínic Barcelona, 08036 Barcelona, Spain., Couselo EM; Department of Medical Oncology. Vall d'Hebron Hospital, Barcelona, Spain & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Neyns B; Department of Medical Oncology, UZ Brussel, Brussels, Belgium., Tucci M; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy., Rossi E; Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Occelli M; Medical Oncology, AO S.Croce e Carle, Cuneo, Italy., Queirolo P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Quaglino P; Department of Dermatology, University of Turin, Turin, Italy., Depenni R; University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy., Merelli B; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Indini A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., da Silva IP; Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113542. Date of Electronic Publication: 2024 Jan 19.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/pathology , Brain Neoplasms*/drug therapy , Brain Neoplasms*/pathology , Radiosurgery*/methods, Humans ; Retrospective Studies ; Proto-Oncogene Proteins B-raf/genetics ; Immunotherapy/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Steroids/therapeutic use

المؤلفون: Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: annamaria.digiacomo@unisi.it., Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Del Vecchio M; Unit of Melanoma, Medical Oncology, Department of Medical Oncology and Hematology, Istituto Nazionale dei Tumori, Milan, Italy., Ferrucci PF; Department of Oncology Gruppo Multimedica, Milan, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Quaglino P; Dermatology Clinic, Department of Medical Science, University of Turin, Italy., Guidoboni M; University of Ferrara, Italy., Marchetti P; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy., Simonetti E; University of Siena, Siena, Italy., Santangelo F; University of Siena, Siena, Italy., Amato G; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Covre A; University of Siena, Siena, Italy., Camerini R; NIBIT Foundation Onlus, Italy., Valente M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy., Mandalà M; University of Perugia, Santa Maria della Misericordia, University Hospital of Perugia, Italy., Giannarelli D; Statistics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy., Calabrò L; University of Ferrara, Italy., Maio M; University of Siena, Siena, Italy; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy; NIBIT Foundation Onlus, Italy.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113531. Date of Electronic Publication: 2024 Jan 11.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/secondary , Melanoma*/pathology , Nitrosourea Compounds* , Organophosphorus Compounds*, Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Ipilimumab/adverse effects ; Nivolumab/adverse effects ; Quality of Life

المؤلفون: Di Giacomo AM; University of Siena, Siena, Italy; Center for Immuno-Oncology. University Hospital of Siena, Viale Bracci, 16, Siena, Italy; NIBIT Foundation Onlus, Italy., Lahn M; IOnctura SA, Avenue Secheron 15, Geneva, Switzerland., Eggermont AM; Princess Máxima Center and the University Medical Center Utrecht, Heidelberglaan 25, 3584 Utrecht, the Netherlands; Comprehensive Cancer Center Munich of the Technical University Munich and the Ludwig Maximiliaan University, Munich, Germany., Fox B; Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, 4805 NE Glisan St. Suite 2N35 Portland, OR 97213, USA., Ibrahim R; Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, D3500, San Francisco, CA, USA., Sharma P; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson, 1515 Holcombe Blvd, Houston, Texas 77030, USA., Allison JP; James P Allison Institute, MD Anderson, 1515 Holcombe Blvd, Texas 77030, USA., Maio M; University of Siena, Siena, Italy; Center for Immuno-Oncology. University Hospital of Siena, Viale Bracci, 16, Siena, Italy; NIBIT Foundation Onlus, Italy. Electronic address: mmaiocro@gmail.com.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Feb; Vol. 198, pp. 113501. Date of Electronic Publication: 2023 Dec 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes, Cytotoxic* , Neoplasms*/drug therapy, Humans ; CTLA-4 Antigen ; Italy ; Immunotherapy

المؤلفون: Calabrò L; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.; Department of Oncology, University Hospital of Ferrara, Ferrara, Italy., Bronte G; Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica Delle Marche, Ancona, Italy.; Clinic of Laboratory and Precision Medicine, National Institute of Health and Sciences On Ageing (IRCCS INRCA), Ancona, Italy., Grosso F; Mesothelioma, Melanoma and Sarcoma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Cerbone L; Mesothelioma, Melanoma and Sarcoma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Delmonte A; Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Nicolini F; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Mazza M; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Di Giacomo AM; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy.; EPigenetic Immune-Oncology Consortium Airc (EPICA), Siena, Italy., Lofiego MF; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy.; EPigenetic Immune-Oncology Consortium Airc (EPICA), Siena, Italy., Crinò L; Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.; Center for Immuno-Oncology, University of Siena, Siena, Italy.; EPigenetic Immune-Oncology Consortium Airc (EPICA), Siena, Italy.; Fondazione Network Italiano per la Bioterapia dei Tumori (NIBIT) Onlus, Siena, Italy.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jan 08; Vol. 14, pp. 1333661. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Mesothelioma*/drug therapy , Mesothelioma, Malignant* , Pleural Neoplasms*, Humans ; Immunotherapy ; Pemetrexed